Thursday, July 14, 2016

Drugmakers Inconsistent in Reporting Side Effects to Different Regulators

Originally published by Robert Kraft.


STAT reports that an analysis published in BMJ Open found that drugmakers generally take an inconsistent approach to reporting side effects to different regulators. The researchers examined 12 brand-name drugs and found on average that drugmakers “filed 77 more side effects reports with the US Food and Drug Administration than with the European Medicines Agency.” On average, only 29% of side effects were reported to both agencies.

From the news release of the American Association for Justice.

Curated by Texas Bar Today. Follow us on Twitter @texasbartoday.

from Texas Bar Today
via Abogado Aly Website

No comments:

Post a Comment